Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension
- 10 September 2022
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 933, 175262
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China-Guangdong Joint Fund (2022A1515011675)
- National Natural Science Foundation of China (82071948)
This publication has 51 references indexed in Scilit:
- Mitochondrial metabolism of reactive oxygen speciesMitochondrion, 2013
- The Tumor Suppressor Mst1 Promotes Changes in the Cellular Redox State by Phosphorylation and Inactivation of Peroxiredoxin-1 ProteinJournal of Biological Chemistry, 2013
- Redox Regulation by Nuclear Factor Erythroid 2-Related Factor 2: Gatekeeping for the Basal and Diabetes-Induced Expression of Thioredoxin-Interacting ProteinMolecular Pharmacology, 2012
- Hypoxic Pulmonary VasoconstrictionPhysiological Reviews, 2012
- A Novel Murine Model of Severe Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF‐κB and Nrf2 cascadesJournal of Pineal Research, 2010
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management EraCirculation, 2010
- Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2010
- Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial RemodelingCirculation, 2008
- Right Ventricular Function in Cardiovascular Disease, Part IICirculation, 2008